Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet therapy for managing HIV infection. This formula integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to replicate within the body, remarkably reducing the viral burden. For